Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791
by
, , , and
Franziska Fries
1,2,3
,
Andreas M. Kany
1,
Sari Rasheed
1,2,
Anna K. H. Hirsch
1,2,3,
Rolf Müller
1,2,3 and
Jennifer Herrmann
1,2,* 1
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Campus E8 1, 66123 Saarbrücken, Germany
2
German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany
3
Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(4), 2011; https://doi.org/10.3390/ijms25042011
Submission received: 15 January 2024
/
Accepted: 22 January 2024
/
Published: 7 February 2024
(This article belongs to the Special Issue Zebrafish as an Experimental Model for Human Disease)
The authors would like to make the following corrections to the original publication [1]. An incorrect version was released due to a production error. During the revision process, one reviewer suggested to convert Table 1 of the original submission [1] into a figure and to change the colors in the graphs. The authors followed these suggestions and re-modeled Table 1 into Figures 2 and 3. As a consequence of the introduced changes, the numbering of the figures and tables changed in the text. Because of the re-modeling of Table 1 to Figures 2 and 3, the reference list was updated. The corrected Figure 2 and Figure 3 appear below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Fries, F.; Kany, A.M.; Rasheed, S.; Hirsch, A.K.H.; Müller, R.; Herrmann, J. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791. [Google Scholar] [CrossRef] [PubMed]
Figure 2.
Linezolid treatment significantly prolongs survival of embryos infected with Staphylococcus aureus. (A) Survival curves of S. aureus-infected embryos (≈50 CFU) treated with linezolid at 2 hpi via different administration routes. Non-infected PBS-injected embryos served as negative control. (B) Fluorescent Integrated Density (FID) of infected untreated and treated embryos at 24 hpt. (C) CFU counts of recovered bacteria from homogenized embryos at 120 hpf. (D) FID of linezolid treatment groups at 120 hpf. Open circles represent living embryos, whereas solid circles show dead embryos. CFU: colony-forming unit; CV: caudal vein; p < 0.0001: ****.
Figure 2.
Linezolid treatment significantly prolongs survival of embryos infected with Staphylococcus aureus. (A) Survival curves of S. aureus-infected embryos (≈50 CFU) treated with linezolid at 2 hpi via different administration routes. Non-infected PBS-injected embryos served as negative control. (B) Fluorescent Integrated Density (FID) of infected untreated and treated embryos at 24 hpt. (C) CFU counts of recovered bacteria from homogenized embryos at 120 hpf. (D) FID of linezolid treatment groups at 120 hpf. Open circles represent living embryos, whereas solid circles show dead embryos. CFU: colony-forming unit; CV: caudal vein; p < 0.0001: ****.
Figure 3.
Treatment of infected embryos with reference antibiotics ((A) ciprofloxacin, (B) tetracycline, (C) cefazolin and (D) vancomycin). Efficacy of tested drugs was determined by means of survival analysis and quantitative fluorescence microscopy. Survival curves of Staphylococcus aureus-infected embryos (≈50 CFU) treated with various reference antibiotics compared to untreated infected embryos (left panel), and Fluorescent Integrated Density (FID) of infected and treated embryos (right panel) at 24 h post treatment (hpt) are shown. A significant increased survival was detected for each antibiotic in at least one delivery method, however, considerable differences were observed amongst the different administration routes. Open circles represent living embryos, whereas solid circles show dead embryos. CV: caudal vein; p < 0.01: **; p < 0.001: ***; p < 0.0001: ****.
Figure 3.
Treatment of infected embryos with reference antibiotics ((A) ciprofloxacin, (B) tetracycline, (C) cefazolin and (D) vancomycin). Efficacy of tested drugs was determined by means of survival analysis and quantitative fluorescence microscopy. Survival curves of Staphylococcus aureus-infected embryos (≈50 CFU) treated with various reference antibiotics compared to untreated infected embryos (left panel), and Fluorescent Integrated Density (FID) of infected and treated embryos (right panel) at 24 h post treatment (hpt) are shown. A significant increased survival was detected for each antibiotic in at least one delivery method, however, considerable differences were observed amongst the different administration routes. Open circles represent living embryos, whereas solid circles show dead embryos. CV: caudal vein; p < 0.01: **; p < 0.001: ***; p < 0.0001: ****.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Fries, F.; Kany, A.M.; Rasheed, S.; Hirsch, A.K.H.; Müller, R.; Herrmann, J. Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791. Int. J. Mol. Sci. 2024, 25, 2011. https://doi.org/10.3390/ijms25042011
AMA Style
Fries F, Kany AM, Rasheed S, Hirsch AKH, Müller R, Herrmann J. Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791. International Journal of Molecular Sciences. 2024; 25(4):2011. https://doi.org/10.3390/ijms25042011
Chicago/Turabian StyleFries, Franziska, Andreas M. Kany, Sari Rasheed, Anna K. H. Hirsch, Rolf Müller, and Jennifer Herrmann. 2024. "Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791" International Journal of Molecular Sciences 25, no. 4: 2011. https://doi.org/10.3390/ijms25042011
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
